RMD · ResMed Inc. · Top AI ETF

Back to holdings

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution.

Close · 3M

+31.19%

Held by 2 AI ETFs

PQUS0.370%

as of Oct 23

AIVL0.262%

as of Oct 23

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals22

Win rate91% (20/22)

Avg buy return+12.83%

PQUSnow 0.370% of fund3 signals

PQUS · Weight increase · 2d

weight 0.450% → 0.480% (+0.030 pp)·stock up 14.2% in the 30 days before

Aug 13·entry $226.74·now $252.86Chased

+11.52%

since Aug 13

PQUS · Weight increase · 2d

weight 0.330% → 0.490% (+0.160 pp)·stock up 4.9% in the 30 days before

Jul 31·entry $210.98·now $252.86Chased

+19.85%

since Jul 31

PQUS · New entry · 1d

stock up 2.6% in the 30 days before

Jul 17·entry $198.99·now $252.86Chased

+27.07%

since Jul 17

AIVLnow 0.262% of fund27 signals

AIVL · Accumulation · 5d

weight 0.248% → 0.262% (+0.014 pp)·stock up 14.0% in the 30 days before

Oct 23·entry $252.86·now $252.86Fresh

0.00%

since Oct 23

AIVL · Accumulation · 5d

weight 0.247% → 0.261% (+0.014 pp)·stock up 13.8% in the 30 days before

Oct 22·entry $253.06·now $252.86Fresh

-0.08%

since Oct 22

AIVL · Accumulation · 5d

weight 0.242% → 0.255% (+0.012 pp)·stock up 9.8% in the 30 days before

Oct 20·entry $245.50·now $252.86Drifting

+3.00%

since Oct 20

AIVL · Accumulation · 5d

weight 0.241% → 0.251% (+0.010 pp)·stock up 6.6% in the 30 days before

Oct 19·entry $239.77·now $252.86Drifting

+5.46%

since Oct 19

AIVL · Accumulation · 5d

weight 0.235% → 0.253% (+0.018 pp)·stock up 6.1% in the 30 days before

Oct 15·entry $242.23·now $252.86Drifting

+4.39%

since Oct 15

AIVL · Weight increase · 2d

weight 0.241% → 0.246% (+0.005 pp)·stock up 7.5% in the 30 days before

Oct 12·entry $234.60·now $252.86Drifting

+7.78%

since Oct 12

AIVL · Weight increase · 2d

weight 0.238% → 0.241% (+0.003 pp)·stock down 7.3% in the 30 days before

Sep 29·entry $222.83·now $252.86Chased

+13.48%

since Sep 29

AIVL · Weight decrease · 3d

weight 0.243% → 0.236% (-0.007 pp)·stock down 4.1% in the 30 days before

Sep 22·entry $221.97·now $252.86

+13.92%

since Sep 22

AIVL · Weight decrease · 2d

weight 0.243% → 0.237% (-0.005 pp)·stock down 2.1% in the 30 days before

Sep 21·entry $223.61·now $252.86

+13.08%

since Sep 21

AIVL · Weight increase · 2d

weight 0.230% → 0.243% (+0.013 pp)·stock up 2.2% in the 30 days before

Sep 15·entry $229.44·now $252.86Chased

+10.21%

since Sep 15

AIVL · Weight decrease · 2d

weight 0.250% → 0.237% (-0.013 pp)·stock up 2.3% in the 30 days before

Sep 3·entry $229.19·now $252.86

+10.33%

since Sep 3

AIVL · Accumulation · 5d

weight 0.236% → 0.250% (+0.013 pp)·stock up 13.8% in the 30 days before

Aug 31·entry $240.10·now $252.86Drifting

+5.31%

since Aug 31

AIVL · Weight increase · 2d

weight 0.242% → 0.248% (+0.006 pp)·stock up 15.2% in the 30 days before

Aug 28·entry $240.33·now $252.86Drifting

+5.21%

since Aug 28

AIVL · Weight decrease · 2d

weight 0.231% → 0.226% (-0.005 pp)·stock up 10.7% in the 30 days before

Aug 17·entry $220.37·now $252.86

+14.74%

since Aug 17

AIVL · Accumulation · 5d

weight 0.216% → 0.232% (+0.016 pp)·stock up 13.3% in the 30 days before

Aug 11·entry $224.84·now $252.86Chased

+12.46%

since Aug 11

AIVL · Accumulation · 5d

weight 0.205% → 0.226% (+0.021 pp)·stock up 7.9% in the 30 days before

Aug 10·entry $220.05·now $252.86Chased

+14.91%

since Aug 10

AIVL · Accumulation · 5d

weight 0.203% → 0.218% (+0.015 pp)·stock up 1.7% in the 30 days before

Aug 7·entry $211.94·now $252.86Chased

+19.31%

since Aug 7

AIVL · Accumulation · 5d

weight 0.204% → 0.231% (+0.026 pp)·stock up 8.5% in the 30 days before

Aug 6·entry $223.24·now $252.86Chased

+13.27%

since Aug 6

AIVL · Weight increase · 3d

stock up 8.0% in the 30 days before

Jul 29·entry $214.29·now $252.86Chased

+18.00%

since Jul 29

AIVL · Weight increase · 2d

stock up 4.3% in the 30 days before

Jul 28·entry $208.96·now $252.86Chased

+21.01%

since Jul 28

AIVL · Weight decrease · 3d

stock up 0.3% in the 30 days before

Jul 23·entry $191.89·now $252.86

+31.77%

since Jul 23

AIVL · Weight decrease · 2d

stock up 2.4% in the 30 days before

Jul 22·entry $192.91·now $252.86

+31.08%

since Jul 22

AIVL · Weight increase · 2d

stock up 5.2% in the 30 days before

Jul 16·entry $202.76·now $252.86Chased

+24.71%

since Jul 16

AIVL · Weight decrease · 3d

stock up 0.3% in the 30 days before

Jul 14·entry $193.01·now $252.86

+31.01%

since Jul 14

AIVL · Weight decrease · 2d

stock up 2.5% in the 30 days before

Jul 13·entry $198.50·now $252.86

+27.39%

since Jul 13

AIVL · Accumulation · 5d

stock up 3.5% in the 30 days before

Jul 10·entry $203.87·now $252.86Chased

+24.03%

since Jul 10

AIVL · Accumulation · 5d

stock up 7.9% in the 30 days before

Jul 9·entry $208.45·now $252.86Chased

+21.30%

since Jul 9

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Oct 25

AIVL has been gradually accumulating RMD over several consecutive sessions in October, lifting its weight to about 0.26%, and PQUS also holds it at 0.37%. This buying conflicts with a Fail verdict that rests on the lack of a margin of safety, although the AI funds may be weighting quality and momentum more than price.

Circle of CompetenceResMed sells sleep apnea and respiratory devices, masks, and cloud software into a chronic-care market with recurring mask and supply replacement, so ten-year unit economics are reasonably predictable.
Economic MoatA large installed base of patients, physician and payer relationships, recurring resupply revenue, and scale in a near-duopoly give it a durable moat, though GLP-1 drugs and competitor re-entry are risks to monitor.
ManagementManagement candour and capital allocation cannot be judged from the data provided, though the company's record of steady buybacks and dividends is a plus that would need verification against actual filings.
Financial HealthA 23.88% ROE and about 10% revenue growth point to strong returns on equity and likely positive owner earnings, though the full ten-year ROE history and margin trend were not provided.
Margin of SafetyAt 23.5x earnings and 21.5x EV/EBITDA the price looks like a fair-to-full price for a wonderful business, with little margin of safety against threats such as GLP-1 adoption.

ResMed sits comfortably inside the circle of competence, has a real moat, and earns high returns on equity. The valuation leaves no clear discount to a conservative estimate of intrinsic value, and management quality is unverified from this data, so the framework withholds a Pass. It would warrant a fresh look at a meaningfully lower price.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.